Company Monitoring Page for Alkermes

latest headlines for company on cafepharma

Why Alkermes Sunk Today
Motley Fool
Thu, 02/22/18 - 11:17 pm
Tags:
Alkermes, ALKS-4230, Nektar, NKTR-214
Alkermes Sets Itself Up for a "Transformative" 2018
Motley Fool
Tue, 02/20/18 - 09:19 am
Tags:
Alkermes
3 Biotech Stocks That Soared This Week
Motley Fool
Sun, 02/18/18 - 10:09 am
Tags:
Alkermes, Immunogen, Sorrento Therapeutics
Alkermes hit with 3 gender discrimination lawsuits from former staffers
Fierce Pharma
Tue, 11/28/17 - 09:00 pm
Tags:
Alkermes, gender discrimination
Alkermes shares rise 6% on Biogen multiple sclerosis drug partnership
Marketwatch
Mon, 11/27/17 - 09:10 am
Tags:
Alkermes, Biogen, MS, multiple sclerosis, ALKS 8700
Alkermes touts equal efficacy of monthly Vivitrol against daily Suboxone
Endpoints
Wed, 11/15/17 - 08:58 pm
Tags:
Alkermes, opioids, Vivitrol, Suboxone, Individor
Alkermes balks at U.S. senator’s probe into 'aggressive' Vivitrol lobbying and marketing
Fierce Pharma
Tue, 11/7/17 - 09:32 pm
Tags:
Alkermes, Vivitrol, lobbying
Once-a-month shot for opioid addiction works as well as daily medication, study finds
Stat
Thu, 10/19/17 - 09:23 am
Tags:
opioids, opioid addiction, Vivitrol, Alkermes, Suboxone
Will third trial be the charm for Alkermes' depression drug?
Fierce Biotech
Tue, 08/22/17 - 12:04 am
Tags:
Alkermes, clinical trials, ALKS 5461, major depressive disorder
Alkermes Continues to Execute
Motley Fool
Fri, 07/28/17 - 11:27 am
Tags:
Alkermes, earnings
Alkermes’ Vivitrol marketing and lobbying put it under gun; pharma says not fair
Fierce Pharma
Fri, 07/14/17 - 08:16 am
Tags:
Alkermes, Vivitrol, drug marketing, lobbying, alcoholism
Alkermes says it's advancing 'full steam' with schizophrenia candidate
Fierce Biotech
Sat, 07/1/17 - 09:28 am
Tags:
Alkermes, schizophrenia, ALKS 3831
Side Effect Weighs on Early Results for Alkermes’ Schizophrenia Drug
Xconomy
Fri, 06/30/17 - 09:40 am
Tags:
Alkermes, schizophrenia, side effects, ALKS 3831, clinical trials
Alkermes claims a success in PhIII schizophrenia head-to-head, but where’s the benefit for patients?
Endpoints
Thu, 06/29/17 - 09:41 pm
Tags:
Alkermes, schizophrenia, ALKS 3831, clinical trials
Can Alkermes' Latest Approval Spark a Rally?
Motley Fool
Wed, 06/7/17 - 11:25 am
Tags:
Alkermes, drug approvals, Aristada, schizophrenia
Alkermes' Revenue Jumps 22%
Motley Fool
Mon, 05/1/17 - 11:34 am
Tags:
Alkermes, earnings
Alkermes execs hit in the pocketbook, filing shows
BioPharma Dive
Mon, 04/17/17 - 11:15 am
Tags:
Alkermes, executive pay
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
TheStreet.com
Thu, 03/9/17 - 11:25 am
Tags:
FDA, drug approvals, Alkermes, ALKS-5461, CytRx, aldoxorubicin, Dynavax Technologies, HEPLISAV-B, Intra-Cellular Therapies, ITI-007, Novan, SB204, Portola Pharmaceuticals, betrixaban, PTC Therapeutics, ataluren, Rigel Pharmaceuticals, fostamatinib, TG Therapeutics, ublituximab
Alkermes' Revenue Soars, Projects an Exciting Year Ahead
TheStreet.com
Thu, 02/16/17 - 10:08 am
Tags:
Alkermes, earnings
Fresh enthusiasm for Cerecor sours as lead drug flops in PhII depression study, shares crater
Endpoints
Wed, 11/30/16 - 09:58 am
Tags:
Cerecor, clinical depression, clinical trials, CERC-501, Eli Lilly, Alkermes

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.